Anaptysbio (ANAB) Operating Margin Growth (1y) (2017 - 2026)
Anaptysbio (ANAB) Operating Margin Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Operating Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Anaptysbio |
1.66 Bn |
1.38 Bn |
- |
-3,637.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-3,637.00 |
| Dec 31, 2025 |
-20,992.00 |
| Sep 30, 2025 |
22,112.00 |
| Jun 30, 2025 |
24,997.00 |
| Mar 31, 2025 |
48,867.00 |
| Dec 31, 2024 |
-67,717.00 |
| Sep 30, 2024 |
98,548.00 |
| Jun 30, 2024 |
79,268.00 |
| Mar 31, 2024 |
264,367.00 |
| Dec 31, 2023 |
149,575.00 |
| Sep 30, 2023 |
115,461.00 |
| Jun 30, 2023 |
112,590.00 |
| Mar 31, 2023 |
4,158.00 |
| Dec 31, 2022 |
256,234.00 |
| Sep 30, 2022 |
-225,799.00 |
| Jun 30, 2022 |
-228,344.00 |
| Mar 31, 2022 |
-308,948.00 |
| Dec 31, 2021 |
-313,738.00 |
| Mar 31, 2021 |
-8,108.00 |
| Dec 31, 2020 |
79,751.00 |
